OptiBiotix Broadens International Footprint with SlimBiome® Rollout

PUBLISHED: 20 May 2025 @ 17:41 | Comments (0) | More info about Fiona Craig

OptiBiotix Health plc (LSE:OPTI) has expanded its global operations through a new partnership with Natural Health Trends Corp, a company listed on NASDAQ. This collaboration debuts the launch of TwinSlim Tomato Soup, a hunger-reducing product developed with SlimBiome®, in Hong Kong, targeting the Chinese market. A U.S. launch is also in the pipeline, aligning with OptiBiotix’s broader strategy to grow its footprint in high-potential regions such as Asia and North America.

The move reflects rising global interest in natural wellness solutions as alternatives to pharmaceutical anti-obesity treatments. With its scientifically backed formulations, OptiBiotix is gaining traction with major international partners and aims to build a stronger brand presence, drive recurring sales, and move toward sustainable profitability.

About OptiBiotix Health plc

Founded in 2012, OptiBiotix Health plc is a pioneering life sciences company focused on microbiome science to support health and disease management. The company is involved in advanced research and development, partnering with academic institutions to engineer microbial strains and formulations used in food and healthcare products. Its core areas of focus include obesity, heart health, and diabetes, with active collaborations across more than 20 countries.

Average Daily Volume: 274,224 shares
Technical Analysis Indicator: Sell
Market Capitalization: £17.87 million

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Ltd. ADVFN Ltd does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.